Why the study?
Does black race compared to white race affect the incidence and progression of CKD in patients with type 2 diabetes receiving clinical trial-level care?
Does black race compared to white race affect the incidence and progression of CKD in patients with type 2 diabetes receiving clinical trial-level care?
In a clinical trial setting, black participants with type 2 diabetes had lower rates of incident CKD compared with white participants, suggesting that real-world racial disparities in CKD may be driven by differences in care rather than biologic propensity.
No takes yet. Share an insight, caveat, or question.
Black participants had lower incident CKD rates than whites; challenges assumptions of biologic predisposition and leaves open care-related drivers of disparities.
Gerber et al. (2018) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: